These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6370501)

  • 1. Comparison of the EMIT phenytoin procedure with old and new antibodies.
    McClellan AC; Chan KM; Lichti DA; Meltzer VN; Ladenson JH
    Clin Chem; 1984 May; 30(5):808-9. PubMed ID: 6370501
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum creatinine concentration and the discrepancy between enzyme multiplied immunoassay technique and gas-liquid chromatographic phenytoin levels.
    Apple FS; Walker FC; Dietzler DN
    Ann Clin Lab Sci; 1983; 13(5):385-92. PubMed ID: 6357047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaprozin and 5-(p-hydroxyphenyl)-5-phenylhydantoin interference in phenytoin immunoassays.
    Datta P
    Clin Chem; 1997 Aug; 43(8 Pt 1):1468-9. PubMed ID: 9267337
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous quantitative assay of phenobarbital, phenytoin, and p-hydroxydiphenylhydantoin by HPLC and a comparison with EMIT.
    Couri D; Suarez del Villar C; Toy-Manning PT
    J Anal Toxicol; 1980; 4(5):227-31. PubMed ID: 7003258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of plasma phenytoin level determinations by EMIT and gas-liquid chromatography in patients with renal insufficiency.
    Nandedkar AK; Williamson R; Kutt H; Fairclough GF
    Ther Drug Monit; 1980; 2(4):427-30. PubMed ID: 7013169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of fosphenytoin in two human plasma phenytoin immunoassays.
    Kugler AR; Annesley TM; Nordblom GD; Koup JR; Olson SC
    Clin Chem; 1998 Jul; 44(7):1474-80. PubMed ID: 9665426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of colorimetric, spectrophotometric & EMIT methods for estimation of phenytoin.
    Jailkhani BL; Jaffery NF
    Indian J Med Res; 1984 May; 79():679-83. PubMed ID: 6392086
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum phenytoin concentrations in uremia.
    Aldwin L; Kabakoff DS
    Ann Intern Med; 1981 Dec; 95(6):785. PubMed ID: 7030168
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of serum phenytoin determination by the substrate-labeled fluorescent immunoassay with gas chromatography, liquid chromatography, radioimmunoassay and "EMIT".
    Wong RC; George R; Yeung R; Burd JF
    Clin Chim Acta; 1980 Jan; 100(1):65-9. PubMed ID: 6985851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity of fosphenytoin in four phenytoin immunoassays.
    Datta P; Dasgupta A
    Clin Chem; 1998 Mar; 44(3):696-7. PubMed ID: 9510897
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-drug sera raised by immunisation with a readily available drug-enzyme conjugate.
    Kamel RS; Landon J; Smith DS
    Clin Chim Acta; 1978 Mar; 84(3):403-5. PubMed ID: 346266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of plasma phenytoin by EMIT in the Monarch centrifugal analyzer: studies on the elimination of within-rotor drift.
    Wenham PR; Barbour HM
    Clin Chem; 1988 Oct; 34(10):2080-3. PubMed ID: 3048782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
    Koizumi F; Kumai M; Ishimori A
    Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
    [No Abstract]   [Full Text] [Related]  

  • 14. Falsely increased immunoassay measurements of total and unbound phenytoin in critically ill uremic patients receiving fosphenytoin.
    Roberts WL; De BK; Coleman JP; Annesley TM
    Clin Chem; 1999 Jun; 45(6 Pt 1):829-37. PubMed ID: 10351992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin and phenobarbital assay by use of EMIT and the ABA-100.
    Van Lente F; Warkentin D; Ohno T
    Clin Chem; 1977; 23(4):761-2. PubMed ID: 321150
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin and phenobarbital concentrations in serum: a comparison of Ames Seralyzer with GLC, TDX, and EMIT.
    Leppik IE; Oles KS; Sheehan ML; Penry JK; Parker DR; Gallagher TK; Caron GP; Rosenfeld W; Salmon JJ
    Ther Drug Monit; 1989; 11(1):73-8. PubMed ID: 2643204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
    Liappis N
    Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatography versus immunoassay (EMIT) for analysis of free phenytoin in serum ultrafiltrate.
    Godolphin W; Trepanier J
    Ther Drug Monit; 1984; 6(3):374-5. PubMed ID: 6390801
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the "EMIT" assay with two iodinated radioimmunoassays for diphenylhydantoin.
    Kampa IS; Jarzabek JJ; Hundertmark JM
    Clin Biochem; 1978 Aug; 11(4):167-8. PubMed ID: 361286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-scale ultracentrifugation as an alternative to ultrafiltration for the determination of the unbound fraction of phenytoin in human serum.
    Jack L; Cunningham C; Watson ID; Stewart MJ
    Ann Clin Biochem; 1986 Sep; 23 ( Pt 5)():603-7. PubMed ID: 3532923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.